Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma

被引：0
|
作者：
Kim, G. P.
Oberg, A. L.
Foster, N. R.
Jaslowski, A.
Flynn, P. J.
Campbell, D.
Hedrick, E.
Gray, L.
Grothey, A.
Alberts, S.
机构：
[1] North Cent Canc Treatment Grp, Rochester, MN USA
[2] Sanofi Aventis, Bridgewater, NJ USA
[3] Genentech BioOncol, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4553
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pimasertib plus gemcitabine in metastatic pancreatic adenocarcinoma: Results of a safety run-in part of a phase II trial
    Verslype, Chris
    Hammel, Pascal
    Hidalgo, Manuel
    Macarulla, Teresa
    Garcia-Carbonero, Rocio
    Andre, Thierry
    Van den Eynde, Marc
    Saez, Berta Laquente
    Milella, Michele
    Raymond, Eric
    Faivre, Thea
    Milner, Alvin
    Tarabaric, Dolores
    Locatelli, Giuseppe
    von Richter, Oliver
    Laffranchi, Bernard
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
    O'Reilly, Eileen M.
    Perelshteyn, Anna
    Jarnagin, William R.
    Schattner, Mark
    Gerdes, Hans
    Capanu, Marinela
    Tang, Laura H.
    LaValle, Joseph
    Winston, Corinne
    DeMatteo, Ronald P.
    D'Angelica, Michael
    Kurtz, Robert C.
    Abou-Alfa, Ghassan K.
    Klimstra, David S.
    Lowery, Maeve A.
    Brennan, Murray F.
    Coit, Daniel G.
    Reidy, Diane L.
    Kingham, T. Peter
    Allen, Peter J.
    ANNALS OF SURGERY, 2014, 260 (01) : 142 - 148
  • [33] Phase II trial of gemcitabine, epirubicin, and G-CSF in patients with metastatic pancreatic cancer
    Raderer, M
    Kornek, GV
    Valencak, J
    Lenauer, A
    Flebiger, W
    Greul, R
    Lang, F
    Schneeweiss, B
    Depisch, D
    Scheithauer, W
    ANNALS OF ONCOLOGY, 1998, 9 : 169 - 169
  • [34] Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma - Clinical and pharmacokinetic data
    Airoldi, M
    Cattel, L
    Passera, R
    Pedani, F
    Milla, P
    Zanon, C
    PANCREAS, 2006, 32 (01) : 44 - 50
  • [35] Gemcitabine and oxaliplatin combination:: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, Joan
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 151 - 152
  • [36] Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, J.
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Garcia-Ribas, I.
    Marfa, X.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2007, 18 (08) : 1359 - 1362
  • [37] FOLFIRI.3 ALTERNATING WITH GEMCITABINE IN PATIENTS WITH UNTREATED METASTATIC PANCREATIC ADENOCARCINOMA: THE RANDOMIZED MULTICENTER AGEO PHASE II TRIAL FIRGEM
    Trouilloud, Isabelle
    Dupont-Gossard, Anne Claire
    Artru, Pascal
    Lecomte, Thierry
    Gauthier, Melanie
    Aparicio, Thomas
    Thirot-Bidault, Anne
    Malka, David
    Lobry, Celine
    Asnacios, Amani
    Lacombe, Sophie
    Fein, Francine
    Dubreuil, Olivier
    Zaanan, Aziz
    Bonnetain, Franck
    Rougier, Philippe
    Taieb, Julien
    ANNALS OF ONCOLOGY, 2012, 23 : 6 - 6
  • [38] Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
    Hess, V.
    Pratsch, S.
    Potthast, S.
    Lee, L.
    Winterhalder, R.
    Widmer, L.
    Cescato, C.
    Lohri, A.
    Jost, L.
    Stillhart, P.
    Pestalozzi, B.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2390 - 2395
  • [39] Postoperative chemoradiation with weekly gemcitabine for pancreatic adenocarcinoma: A phase II trial.
    Mattiucci, G.
    Morganti, A. G.
    Ippolito, E.
    Macchia, G.
    Smaniotto, D.
    Valentini, V.
    Antinori, A.
    Magistrelli, P.
    Cellini, N.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S526 - S526
  • [40] Quality of life in a multicenter phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma
    Aybar, Pablo Emilio Serrano
    Herman, Joseph M.
    Zalupski, Mark
    Kim, Edward Jae-Hoon
    Ben-Josef, Edgar
    Bekaii-Saab, Tanios S.
    Wolfgang, Christopher Lee
    Laheru, Daniel A.
    Moore, Malcolm J.
    Dawson, Laura A.
    Ringash, Jolie
    Wei, Alice Chia-chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345